# Impact of Solarplast® on Immunity in Active Smokers and Non-smokers

> **NCT05162820** · NA · COMPLETED · sponsor: **University of Memphis** · enrollment: 50 (actual)

## Conditions studied

- Immunity
- Smoking, Cigarette

## Interventions

- **DIETARY_SUPPLEMENT:** 100 mg Solarplast
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05162820
- **Lead sponsor:** University of Memphis
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-22
- **Primary completion:** 2023-06-27
- **Final completion:** 2023-08-24
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05162820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05162820, "Impact of Solarplast® on Immunity in Active Smokers and Non-smokers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05162820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*